Literature DB >> 11011844

Biological and environmental determinants of plasma homocysteine.

J Schneede1, H Refsum, P M Ueland.   

Abstract

This article gives an overview over common physiological, lifestyle, and pathological conditions that may modulate the homocysteine status. The interplay of several environmental factors, including age, gender, nutrition, smoking, and coffee consumption and physical activity with commonly used drugs and prevalent diseases are described. In most cases, an abnormal homocysteine status is not caused by a single factor alone but often is the result of combined effects. We address these frequently found "clusters" of homocysteine-modulating factors. Finally, we give an overview of likely causes of hyperhomocysteinemia found in an authentic material. This material is based on 2462 routine measurements of plasma total homocysteine carried out at the Haukeland University Hospital. The data represent the total number of combined homocysteine and methylmalonic acid determinations, requested by general practitioners in Norway during February 1998.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11011844     DOI: 10.1055/s-2000-8471

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  25 in total

1.  Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.

Authors:  Vicki L Ellingrod; Stephan F Taylor; Gregory Dalack; Tyler B Grove; Michael J Bly; Robert D Brook; Sebastian K Zöllner; Rodica Pop-Busui
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

2.  MAT1A variants modulate the effect of dietary fatty acids on plasma homocysteine concentrations.

Authors:  T Huang; K Tucker; Y Lee; J Crott; L Parnell; J Shen; C Smith; J Ordovas; D Li; C Lai
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-12-24       Impact factor: 4.222

3.  Functional inference of the methylenetetrahydrofolate reductase 677C > T and 1298A > C polymorphisms from a large-scale epidemiological study.

Authors:  Arve Ulvik; Per M Ueland; Ase Fredriksen; Klaus Meyer; Stein Emil Vollset; Geir Hoff; Jørn Schneede
Journal:  Hum Genet       Date:  2006-11-18       Impact factor: 4.132

4.  Factors associated with serum total homocysteine level in type 2 diabetes.

Authors:  Yumi Masuda; Akira Kubo; Akatsuki Kokaze; Masao Yoshida; Nobuki Fukuhara; Yutaka Takashima
Journal:  Environ Health Prev Med       Date:  2008-03-29       Impact factor: 3.674

5.  Relationship between increase of serum homocysteine caused by smoking and oxidative damage in elderly patients with cardiovascular disease.

Authors:  Shengfang Chen; Ping Wu; Lin Zhou; Yuqin Shen; Yunjie Li; Haoming Song
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 6.  Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management.

Authors:  Anna K Jönsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 5.749

7.  A polymorphism in the methylenetetrahydrofolate reductase gene predisposes to colorectal cancers with microsatellite instability.

Authors:  B Shannon; S Gnanasampanthan; J Beilby; B Iacopetta
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

8.  Trait anger, hostility, serum homocysteine, and recurrent cardiac events after percutaneous coronary interventions.

Authors:  Eun Kyeung Song; Youn-Jung Son; Terry A Lennie
Journal:  Am J Crit Care       Date:  2009-11       Impact factor: 2.228

9.  Functional polymorphisms of folate-metabolizing enzymes in relation to homocysteine concentrations in systemic lupus erythematosus.

Authors:  Carolyn M Summers; Andrew J Cucchiara; Eleni Nackos; Andrea L Hammons; Elisabeth Mohr; Alexander S Whitehead; Joan M Von Feldt
Journal:  J Rheumatol       Date:  2008-09-01       Impact factor: 4.666

10.  Glycine N -methyltransferase deficiency: a new patient with a novel mutation.

Authors:  P Augoustides-Savvopoulou; Z Luka; S Karyda; S P Stabler; R H Allen; K Patsiaoura; C Wagner; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.